Osteoarthritis

Osteoarthritis (OA) is the most common form of arthritis, a chronic disease affecting the tissues of movable joints. It involves changes in articular cartilage, underlying bone, the joint lining, and supporting tissues, and commonly produces joint pain, stiffness, and reduced function. The knees, hips, hands, and spine are frequent sites. Although associated with increasing age, osteoarthritis is neither an inevitable consequence of aging nor simply the mechanical wearing away of cartilage. Its development involves interacting mechanical and biological processes, including tissue damage and inadequate repair. (niams.nih.gov)

Osteoarthritis is an important cause of disability and reduced quality of life. The World Health Organization estimated that approximately 528 million people worldwide were living with it in 2019. Its manifestations range from structural changes with few symptoms to substantial pain and mobility limitations; progression is not uniform. Clinical assessment, rehabilitation, symptom-relieving medicines, and selected surgical procedures form the principal approaches to management, while research investigates earlier detection, disease mechanisms, and treatments that might modify joint damage. (who.int)

Definition, Terminology, and Classification

Osteoarthritis, abbreviated OA, is a chronic disorder of the whole synovial joint, not simply the loss of articular cartilage. Its defining abnormalities can involve the cartilage covering the joint surfaces, the underlying bone, synovial lining, capsule, ligaments, and, in the knee, menisci. These tissues form an interacting mechanical and biological system: altered loading, tissue damage, and unsuccessful repair can produce cartilage breakdown, bone remodeling, osteophytes—bony outgrowths at joint margins—and synovial inflammation. Individual joints differ in the combination and extent of these changes; complete cartilage loss is not required for the disease to exist. The whole-joint definition therefore encompasses abnormalities that cannot be described by cartilage thickness alone. (oarsi.org)

Osteoarthrosis, arthrosis, and degenerative joint disease are alternative terms used for substantially the same condition. The US National Library of Medicine lists osteoarthrosis and degenerative arthritis among the entry terms for osteoarthritis in its Medical Subject Headings vocabulary. “Degenerative” describes tissue deterioration but does not establish that OA results from passive, inevitable “wear and tear.” Joint tissues undergo active biological changes, and inflammatory processes can accompany degeneration. Thus, the terminology does not justify classifying osteoarthrosis as a separate, strictly non-inflammatory disease, nor does the name osteoarthritis imply that its mechanisms are identical to those of rheumatoid arthritis. (ncbi.nlm.nih.gov)

The conventional etiological classification distinguishes primary, or idiopathic, OA, for which no single preceding cause is identified, from secondary OA associated with a recognized joint injury, abnormality, or disease. Secondary examples include OA following a joint fracture or ligament injury, and OA associated with abnormal joint development or an earlier inflammatory joint disorder. This distinction records a clinically meaningful antecedent, but it is not a sharp division between two biological diseases. Primary OA can still involve inherited susceptibility, age-associated changes, obesity, and mechanical loading; secondary OA can involve these same influences in addition to the identified antecedent. The 2011 OARSI–FDA disease-definition working group emphasized that contributing factors may differ between joints and even between compartments of one joint. (merckmanuals.com)

Classification by distribution is separate from classification by cause. Localized OA denotes involvement restricted to one joint or anatomical joint group, whereas multiple-joint or polyarticular OA describes involvement of several joints or joint groups. Generalized OA has traditionally denoted a broader pattern, often including several hand joints together with other sites, but it has no universally accepted numerical threshold. A 2014 systematic review by Amanda E. Nelson and colleagues identified at least 15 definitions among 30 studies that explicitly defined generalized OA. Studies differed in the joints examined, the number required, and whether clinical or radiographic findings determined involvement. Consequently, descriptions such as “hand and knee OA” convey information that the label “generalized” alone does not provide. (merckmanuals.com)

A further distinction separates structural OA from symptomatic OA. Structural OA refers to demonstrable joint abnormalities, commonly characterized in research by imaging; symptomatic OA includes symptoms attributable to the affected joint, particularly pain, stiffness, and functional limitation. In 2011, Nancy E. Lane and colleagues distinguished the structural “disease” from the patient-experienced “illness.” These categories overlap imperfectly: substantial abnormalities on an X-ray may coexist with little pain, while symptoms do not establish the presence or extent of structural OA by themselves. “Radiographic OA” is therefore an imaging-based case definition, not a synonym for symptomatic disease; studies combining radiographic findings with pain assess a different group from studies counting structural changes alone. (oarsijournal.com)

Epidemiology and Population Burden

The World Health Organization (WHO), in its fact sheet dated 14 July 2023, reported that approximately 528 million people worldwide were living with osteoarthritis in 2019, an increase of 113% in case numbers since 1990. This increase must be distinguished from a change in age-standardized prevalence, which compares populations using a common age distribution. Haolin Long and colleagues’ 2022 analysis of the Global Burden of Disease Study 2019 estimated that age-standardized prevalence rose from approximately 6,170 to 6,350 per 100,000 between 1990 and 2019—a much smaller proportional change than the increase in affected people. Growing populations and increasing numbers of older adults therefore contribute substantially to the expanding burden; the case-count increase does not mean that risk at a given age doubled. (who.int)

In the estimates cited by WHO, approximately 73% of affected people were older than 55 years and 60% were female. These are proportions of the affected population, not the percentages of all older adults or all women who have osteoarthritis. The 2019 analysis estimated age-standardized prevalence at approximately 7,280 per 100,000 females and 5,320 per 100,000 males, indicating that the sex difference persisted after adjustment for population age structure. Osteoarthritis also affects working-age adults, although prevalence increases markedly with age; it is not an inevitable consequence of ageing. (who.int)

The knee contributes the largest joint-specific burden. WHO reported approximately 365 million people with knee osteoarthritis in 2019; the underlying analysis estimated approximately 142 million with hand involvement and 33 million with hip involvement. Joint-specific counts cannot simply be added to obtain a unique-person total because an individual can have disease at several sites. Population ageing, obesity, and joint injury are expected to increase demand for care. A separate GBD analysis published in 2023 projected that knee osteoarthritis cases would increase by 74.9% between 2020 and 2050, reaching approximately 642 million. These are model-based projections rather than observed outcomes; the analysis found that demographic changes generally contributed more to projected case growth than changes in age-standardized prevalence. (who.int)

Population burden includes disability and service needs as well as prevalence. WHO estimated that approximately 344 million affected people had moderate or severe disease that could benefit from rehabilitation. This figure represents estimated potential need, not the number receiving rehabilitation. The 2023 GBD analysis estimated 21.7 million years lived with disability attributable to osteoarthritis in 2020, with a 95% uncertainty interval of 10.2–47.6 million. This measure weights time lived with disease by severity rather than counting every case equally. Osteoarthritis ranked seventh among causes of years lived with disability in adults aged 70 years or older. Increasing case numbers place additional demands on health systems for continuing clinical care, rehabilitation, and joint replacement, with access constrained by resources and affordability. (who.int)

Comparisons between population studies depend strongly on case definitions. Radiographic studies identify structural abnormalities on X-rays, whereas symptomatic definitions generally require symptoms together with structural evidence; self-reported diagnoses and clinical records capture different populations. Daniela Pereira and colleagues’ 2011 systematic review of 72 papers found higher prevalence estimates with radiographic definitions and substantial variation even among studies examining the same joint with the same definition. The 2023 GBD analysis used symptomatic, radiographically confirmed osteoarthritis as its reference definition and statistically adjusted alternative definitions to that reference. Consequently, an imaging-based prevalence estimate, a count of clinically diagnosed patients, and an estimate of rehabilitation need describe related but non-interchangeable aspects of population burden. (pubmed.ncbi.nlm.nih.gov)

Joint Structure and Disease Mechanisms

In a healthy synovial joint, articular cartilage covers the opposing bone surfaces, permitting low-friction movement while distributing compressive loads. Its chondrocytes maintain an extracellular matrix in which a predominantly type II collagen network provides tensile strength, while water-binding proteoglycans, particularly aggrecan, provide resistance to compression. Subchondral bone—the bone immediately beneath the cartilage—supports this load-bearing surface. The fibrous joint capsule encloses the joint, and its inner synovial lining contributes to the lubricating synovial fluid. Ligaments constrain excessive movement and help maintain alignment. Where present, menisci improve the fit between joint surfaces and redistribute forces; in the knee, their circumferential collagen fibres convert compression into tensile “hoop” stresses. These tissues function as an integrated mechanical system rather than independent structures. (pmc.ncbi.nlm.nih.gov)

Osteoarthritis develops when tissue damage and matrix breakdown exceed effective repair. Chondrocytes do not simply become inactive: they can increase matrix synthesis while also producing matrix-degrading enzymes, forming cell clusters, or adopting an enlarged, hypertrophic phenotype. These responses fail to reconstruct the original cartilage architecture. Matrix metalloproteinase-13 (MMP-13) cleaves type II collagen, while aggrecanases, including ADAMTS-4 and ADAMTS-5, cleave aggrecan. Loss of these components compromises the cartilage’s mechanical properties, encouraging further damage under loading. Experimental evidence distinguishes enzyme activity from passive abrasion: in 2005, Sonya S. Glasson and colleagues reported that deleting the catalytic domain of ADAMTS-5 significantly reduced cartilage destruction in mice after surgically induced joint instability. This established its importance in that model, without demonstrating an identical contribution in every form of human disease. (nature.com)

Subchondral bone also undergoes active remodelling. Altered bone resorption and formation can change its architecture, with thickening and sclerosis in established disease. Osteophytes are new cartilage-and-bone outgrowths at joint margins, not fragments worn off the articular surface. Bone changes can alter the mechanical environment of cartilage, while biochemical signals connect the two tissues. In a 2013 study, Gehua Zhen and colleagues found increased active transforming growth factor beta-1 (TGF-β1) in subchondral bone after anterior cruciate ligament transection in mice, as well as elevated concentrations in human osteoarthritic specimens. In the experimental models, excessive signalling promoted abnormal bone formation and blood-vessel growth; inhibiting subchondral TGF-β signalling reduced cartilage degeneration. This illustrates a bone–cartilage interaction rather than proof of a universal initiating pathway. (nature.com)

Synovial inflammation is another interacting component. The synovium may thicken, accumulate inflammatory cells, and produce mediators that influence cartilage and other joint tissues. Matrix fragments and molecules released by damaged cells can activate innate immune pathways, including Toll-like receptor signalling. Synovial cells and chondrocytes can then release cytokines and additional degradative enzymes, creating feedback between tissue injury and inflammation. These processes vary in extent between joints and individuals; synovitis, cartilage loss, bone remodelling, and osteophyte formation need not occur in one obligatory sequence. Their functional interdependence makes the first pathological event difficult to identify. (pmc.ncbi.nlm.nih.gov)

Mechanical loading and biochemical signalling therefore operate together. Chondrocytes sense deformation and changes in their surrounding matrix through mechanotransduction, converting physical stimuli into cellular responses. Joint instability or altered meniscal function can redistribute stress, while matrix degradation changes how that stress reaches cells. Normal loading is not equivalent to damaging overload, and osteoarthritis is not adequately explained as simple “wear and tear.” The established whole-joint mechanisms include disrupted tissue maintenance, proteolytic matrix destruction, altered bone turnover, and inflammatory feedback; the initiating events and their relative importance remain heterogeneous and incompletely resolved. (pubmed.ncbi.nlm.nih.gov)

Causes and Risk Factors

Advancing age increases susceptibility to osteoarthritis (OA), but the disease is not an inevitable consequence of aging or simply the accumulated “wear” of normal joint use. Older joint tissues may respond less effectively to damage and repair signals. In a 2014 laboratory study, Richard F. Loeser and colleagues found that cartilage cells from older human donors showed reduced responses to insulin-like growth factor 1 and osteogenic protein 1, factors that stimulate cartilage-matrix production; experimentally induced oxidative stress also impaired these responses. Such findings identify mechanisms of age-associated vulnerability rather than a sufficient cause of disease. Younger adults can develop OA, particularly after injury or in joints with structural abnormalities. (niams.nih.gov)

Inherited predisposition likewise affects probability rather than determining an individual outcome. Family history is a recognized risk factor, and common OA has a complex genetic architecture rather than a single universal genetic cause. A 2021 genome-wide association study meta-analysis comprising 826,690 individuals, including 177,517 with OA, identified 100 independently associated risk variants across 11 disease phenotypes; 52 had not previously been associated with OA. Genetic effects differed between weight-bearing and non-weight-bearing joints, and some associations were specific to sex or earlier onset. These results help explain why inherited susceptibility can vary by anatomical site, while leaving substantial scope for environmental and mechanical exposures. (niams.nih.gov)

Obesity increases mechanical loading of weight-bearing joints, particularly the knees and hips, but additional biological pathways are under investigation. Adipose tissue produces signaling molecules, including leptin, that may influence cartilage metabolism and inflammation. Research using human OA cartilage and synovial fluid, together with experimental injections in rats, found relationships between leptin, body mass index, and cartilage-cell activity. These observations do not establish leptin as a sufficient cause of OA. Evidence is also not uniform across joints: a population-based analysis published in 2012 found no statistically significant adjusted association between serum leptin concentration and hand OA. Mechanical loading and metabolic signaling therefore represent distinct, potentially interacting explanations rather than interchangeable measures of risk. (niams.nih.gov)

Previous joint injury is an important exposure, including injuries sustained during sport. A 2004 study by L. Stefan Lohmander and colleagues examined female soccer players 12 years after anterior cruciate ligament injury. Among the 67 women who underwent radiography, 34, or 51%, met the study’s criterion for radiographic knee OA; their mean age was 31 years. This selected injured cohort does not describe the risk of soccer participation generally. Sports-related injury and demanding training should also be distinguished from ordinary recreational activity: Grace H. Lo and colleagues’ 2017 cross-sectional analysis of 2,637 Osteoarthritis Initiative participants found no increased likelihood of symptomatic knee OA among self-selected recreational runners. Its observational design does not establish that running prevents disease. (pubmed.ncbi.nlm.nih.gov)

Repetitive occupational loading is another distinct exposure. Prolonged kneeling, squatting, and heavy lifting may combine sustained joint bending with substantial mechanical loads. In David Coggon and colleagues’ 2000 case–control study, 518 patients listed for knee OA surgery were compared with 518 community controls. After adjustment for body mass index, previous knee injury, and Heberden’s nodes, prolonged occupational kneeling or squatting was associated with an odds ratio of 1.9, while regularly lifting loads of at least 25 kilograms was associated with an odds ratio of 1.7. These estimates concern particular workplace exposures and severe disease selected for surgery, not all movement or exercise. (pubmed.ncbi.nlm.nih.gov)

Abnormal alignment and joint shape can concentrate loads unevenly. Bow-legged, or varus, knee alignment increases medial tibiofemoral loading; knock-kneed, or valgus, alignment increases lateral loading. Leena Sharma and colleagues’ 2010 longitudinal study found that varus alignment was associated with incident radiographic knee OA over 30 months, with an adjusted odds ratio of 1.49. Both alignment patterns were associated with progression in the compartment bearing greater load. Structural abnormalities elsewhere also confer susceptibility: the 2005 Rotterdam Study found that acetabular dysplasia was associated with incident radiographic hip OA. Pre-existing disorders can provide another route to joint damage; for example, osteonecrosis may lead to collapse of the joint surface and subsequent OA. (pubmed.ncbi.nlm.nih.gov)

Anatomical Patterns

At the knee, osteoarthritis can involve the medial and lateral tibiofemoral compartments, where the femur articulates with the tibia, and the patellofemoral compartment, between the kneecap and femur. Disease may affect one compartment or occur in combinations rather than uniformly throughout the knee. Pain during weight-bearing and restricted bending or straightening can interfere with walking and stair use. Patellofemoral involvement is particularly relevant to activities performed with a bent, loaded knee, although symptoms do not reliably identify the affected compartment. In a British study of 745 painful knees in adults older than 50, using data collected in 2002–2006, 24% had isolated radiographic patellofemoral disease, 4% isolated tibiofemoral disease, and 40% involvement of both; these figures describe a selected symptomatic sample, not population prevalence. (orthoinfo.aaos.org)

At the hip, the affected articulation is the ball-and-socket joint between the femoral head and the acetabulum of the pelvis. Changes in its cartilage and underlying bone can accompany reduced movement and pain during loading. The characteristic pain location is the groin, but pain may also extend into the thigh, buttock, or knee: the site where joint pain is perceived therefore need not identify its anatomical origin. Restricted hip movement can make walking, rising from a chair, and bending to tie a shoe difficult. A painful hip may also produce a limp, linking impairment at this proximal joint to the movement of the lower limb as a whole. (orthoinfo.aaos.org)

In the hand, common sites are the distal interphalangeal joints nearest the fingertips, the proximal interphalangeal joints in the middle of the fingers, and the first carpometacarpal joint at the thumb base. Hard bony enlargements at the distal joints are called Heberden’s nodes; corresponding enlargements at the proximal joints are Bouchard’s nodes. These changes can accompany stiffness, altered finger shape, and reduced movement. Thumb-base disease particularly affects gripping and pinching: pain and weakness may make opening a jar or turning a key difficult. Thus, hand involvement can impair both forceful grasp and the precise manipulation needed for everyday tasks, even though the affected joints do not bear body weight in the manner of the hip or knee. (assh.org)

In the spine, osteoarthritis affects the paired facet joints, also called zygapophyseal joints, between adjacent vertebrae. These are cartilage-covered synovial articulations that help guide spinal movement and maintain stability. They are anatomically distinct from the intervertebral discs situated between vertebral bodies, although facet-joint disease and disc degeneration can coexist and influence the same spinal motion segment. Neck or lower-back pain therefore cannot automatically be attributed to facet osteoarthritis; disc-related disorders, including a herniated disc, and other spinal or soft-tissue conditions represent separate possible sources. Structural facet changes also occur without corresponding pain. In a 2008 community-based study, Leonid Kalichman and colleagues assessed 188 Framingham Heart Study participants and found lumbar facet osteoarthritis on computed tomography in 59.6% of men and 66.7% of women, but no association with reported lower-back pain at any examined lumbar level. (pubmed.ncbi.nlm.nih.gov)

Symptoms, Clinical Course, and Functional Effects

Joint pain commonly appears during use of an affected joint and may lessen with rest. Symptoms often begin gradually in one or a few joints, but their intensity varies substantially between individuals and over time. Some people have mild discomfort with little interference in daily life; others develop persistent pain and substantial limitations. In more advanced symptomatic disease, pain may also occur at night. Stiffness is characteristic on waking or after inactivity, such as prolonged sitting, and usually lasts less than 30 minutes. This brief stiffness after rest is distinct from the sustained restriction of movement that can develop as joint structure changes. (niams.nih.gov)

Other manifestations include swelling in or around the joint, particularly after substantial use, reduced range of motion, and a sensation of looseness or instability. Affected knees may produce grinding or scraping sounds during movement and may buckle as muscle and ligament weakness develops. These manifestations do not necessarily occur together or indicate the same degree of impairment. Functional difficulties can include rising from a chair or toilet, negotiating steps, walking across a parking area, and gripping a cooking pan. Pain-related reduction in activity can contribute to muscle weakness, which may place additional stress on the joint. (niams.nih.gov)

The clinical course can include flares—episodes of increased symptoms superimposed on the usual level of discomfort. Definitions vary between studies, particularly concerning the minimum duration and magnitude of worsening. A 2021 community-based study followed 744 adults aged at least 40 years who had, or were at risk of, knee osteoarthritis for 13 weeks. It defined a flare as a sudden worsening of signs and symptoms lasting at least 24 hours; 376 participants reported 568 flares. Median duration was five days, with an interquartile range of three to eight days. Activity-related and psychosocial exposures were associated with flare onset, but these observational associations do not establish that each exposure causes flares in every affected person. (pubmed.ncbi.nlm.nih.gov)

Long-term symptoms do not invariably worsen rapidly or steadily. In a 2014 analysis by Jamie E. Collins and colleagues, 1,753 participants with radiographic, symptomatic knee osteoarthritis were followed with annual pain assessments for six years. Five modeled pain trajectories differed chiefly in their level of pain; none showed substantial average worsening. Nevertheless, approximately one fifth of participants in the two highest-pain groups underwent knee replacement during follow-up. The findings therefore describe heterogeneous courses under observed care, rather than proving that severe symptoms never progress. Stable group averages can also coexist with individual fluctuations or deterioration. (pmc.ncbi.nlm.nih.gov)

Structural abnormalities visible on an X-ray do not correspond closely enough to symptoms to serve as a direct measure of suffering or functional capacity. A person with marked radiographic changes may experience little pain, whereas symptom burden cannot be inferred reliably from an image alone. Structural severity, pain, and physical function are consequently related but distinct dimensions of disease. The Osteoarthritis Research Society International emphasizes both this imperfect correspondence and the possibility of no progression, or even improvement, rather than an inevitable transition to severe disease. (oarsi.org)

For some people, mobility restrictions and interrupted sleep extend the effects beyond the affected joint, reducing participation in everyday activities and enjoyment of life. Difficulty with routine transfers, walking, or household tasks can limit independence. Pain and other symptoms may be accompanied by fatigue and depressed mood, affecting psychological well-being as well as physical functioning. These consequences are not universal: symptom severity ranges widely, and relatively mild disease may leave daily activities largely unaffected. Their extent therefore forms a separate aspect of quality of life, not a consequence that can be assumed from radiographic damage alone. (niams.nih.gov)

Diagnosis and Assessment

Clinical diagnosis rests on the history and physical examination rather than a single confirmatory test. History-taking establishes the affected joints, onset and course of symptoms, relationship of pain to activity, duration of stiffness, previous injuries, other illnesses, and medication use. Assessment also distinguishes identifying the disease from measuring its consequences: limitations in walking, hand use, and everyday activities need not correspond to the extent of structural damage. The United Kingdom’s National Institute for Health and Care Excellence (NICE), in guideline NG226 published on 19 October 2022, specifies clinical diagnosis without imaging for people aged 45 years or older who have activity-related joint pain and either no morning joint stiffness or stiffness lasting no more than 30 minutes. These are criteria within named guidance, not a universal age-based definition of the disease. (niams.nih.gov)

When radiographs are obtained, characteristic findings include joint-space narrowing, osteophytes—bony outgrowths at joint margins—and changes in the underlying bone. Early joint damage may not appear on plain radiographs. Structural grading provides a standardized description of these abnormalities rather than a direct measurement of pain or disability. J. H. Kellgren and J. S. Lawrence introduced their radiographic classification in 1957; its five grades range from 0 to 4. Grade 0 denotes no radiographic features, grade 2 includes definite osteophytes with possible joint-space narrowing, and grade 4 includes large osteophytes, marked narrowing, sclerosis, and definite deformity of the bone ends. Radiographic grade and symptom severity are distinct assessments: an image does not establish how much pain a person experiences or how effectively the joint functions. NICE accordingly places symptoms and physical function, rather than imaging severity alone, at the center of clinical assessment. (niams.nih.gov)

Imaging is therefore selective rather than a routine prerequisite for diagnosing a typical presentation. NICE reserves diagnostic imaging for atypical features or suspicion of an alternative or additional disorder, and does not recommend routine imaging for follow-up or to guide nonsurgical management. Magnetic resonance imaging can depict soft-tissue damage in and around a joint; the US National Institute of Arthritis and Musculoskeletal and Skin Diseases identifies locking or giving way as examples in which it may assist evaluation. Imaging also has a separate role in surgical assessment, where the distribution and severity of structural changes inform planning. That role does not imply that MRI is routinely required to confirm osteoarthritis. (nice.org.uk)

The differential diagnosis includes rheumatoid arthritis, crystal arthritis such as gout, and joint infection. Laboratory investigations address these alternatives rather than confirming osteoarthritis itself. When inflammatory arthritis is suspected, selective blood testing may include inflammatory markers, rheumatoid factor, and anti-cyclic citrullinated peptide antibodies. These results require interpretation alongside the clinical findings: rheumatoid factor can occur without rheumatoid arthritis, while rheumatoid arthritis can occur with normal blood-test results. Joint-fluid sampling has a different diagnostic function, allowing examination for crystals or evidence of infection when the presentation warrants it. (nice.org.uk)

An acutely painful, hot, swollen joint requires consideration of infection even when osteoarthritis is already present. The 2023 guideline for septic arthritis in native joints emphasizes joint-fluid aspiration and bacterial identification, supplemented by a white-cell count and crystal examination. Microscopy can identify urate crystals in gout, but finding crystals does not exclude simultaneous infection. Conversely, a normal blood C-reactive protein concentration cannot by itself exclude septic arthritis. These investigations resolve a specific differential diagnosis; they are not routine tests for uncomplicated osteoarthritis. (jbji.copernicus.org)

Nonpharmacological Management and Rehabilitation

Therapeutic exercise targets muscle strength, joint mobility, and aerobic endurance rather than cartilage loss alone. Strengthening exercises use resistance, such as weights or elastic bands, to improve muscular support around affected joints; aerobic approaches include walking, cycling, and swimming. Range-of-motion, balance, and aquatic exercises address additional functional limitations. The United Kingdom’s National Institute for Health and Care Excellence (NICE), in its 2022 guideline NG226, identifies tailored exercise as a core treatment and includes supervised sessions as an option. Its evidence assessment found clinically important benefits for symptoms and physical function, although evidence comparing supervised with unsupervised delivery was limited. Initial discomfort and sustained adherence are explicit considerations in exercise programmes. (health.nih.gov)

Clinical studies distinguish patient-reported outcomes from measured physical performance and biological mechanisms. Outcomes include pain, difficulty performing everyday activities, walking speed, six-minute walking distance, and health-related quality of life. In the Intensive Diet and Exercise for Arthritis (IDEA) randomized controlled trial, published by Stephen P. Messier and colleagues in 2013, pain and function were assessed with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The study also measured knee compressive force and circulating interleukin-6, an inflammatory marker. These measurements assess different dimensions of treatment response: an improvement in walking ability or pain does not itself establish a change in joint structure. (pubmed.ncbi.nlm.nih.gov)

Weight-management interventions have been studied particularly in knee osteoarthritis associated with overweight or obesity. IDEA enrolled 454 adults aged at least 55 years and compared dietary weight loss, exercise, and their combination over 18 months. Mean weight loss was 11.4% with diet plus exercise, 9.5% with diet alone, and 2.0% with exercise alone. The combined intervention produced better pain and functional outcomes than either component alone; the dietary groups also had greater reductions in interleukin-6 than the exercise-only group. NICE’s 2022 guidance describes greater symptomatic and functional benefits with greater weight loss, stating that 10% is likely to be more beneficial than 5%. However, IDEA’s structural analysis, involving repeat radiographs in 325 participants and magnetic resonance imaging in 105, did not demonstrate a structural advantage for dietary weight loss over exercise alone during the study period. Symptom relief, reduced loading, and structural disease modification therefore remain distinct outcomes. (pubmed.ncbi.nlm.nih.gov)

Patient education explains the condition, symptom fluctuations, treatment benefits and limitations, and the role of continued activity. Structured self-management programmes combine information with practical methods such as goal setting, pain-coping skills, motivational coaching, and weight-management counselling. NICE found that packages incorporating education or behavioural approaches could improve function compared with those approaches alone, but were not consistently superior to individual active treatments such as exercise. Within rehabilitation, physical therapy focuses on joint function and exercise, while occupational therapy addresses performance of daily tasks and methods of protecting joints. Examples include changing how objects are carried and using jar openers to reduce gripping demands in hand disease. These interventions address activity limitations without implying restoration of damaged cartilage. (nice.org.uk)

Walking aids—including sticks, crutches, walking frames, and rollators—can improve balance and walking patterns or reduce weight bearing through an affected lower-limb joint. Their clinical role is to support mobility and independence, including participation in exercise. Braces, splints, insoles, and other supports have more selective roles. NICE NG226 does not endorse their routine use: its specified circumstances combine joint instability or abnormal biomechanical loading, exercise that is ineffective or unsuitable without a device, and a reasonable expectation of improved movement and function. Its evidence review also notes possible pressure-related harms, including blistering. Device selection and daily-activity adaptations consequently form part of functional rehabilitation rather than a uniform treatment for every affected joint. (nice.org.uk)

Medicines and Intra-articular Treatments

Nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen and diclofenac, relieve pain and reduce inflammation by inhibiting cyclooxygenase enzymes and decreasing prostaglandin synthesis. Their analgesic effects do not establish that they restore cartilage or alter the underlying disease course. The United Kingdom’s National Institute for Health and Care Excellence (NICE), in guideline NG226 published on 19 October 2022, places medicines alongside nonpharmacological treatment, particularly to support therapeutic exercise. It specifies the lowest effective dose for the shortest possible duration, recommends topical NSAIDs for knee osteoarthritis, and considers them for other affected joints. Oral NSAIDs occupy a subsequent role when topical treatment is ineffective or unsuitable. (ncbi.nlm.nih.gov)

Topical delivery reduces, but does not eliminate, systemic exposure. For example, the prescribing information for diclofenac sodium 1% gel reports that application of 4 g to one knee four times daily produces approximately 6% of the systemic exposure associated with oral diclofenac 50 mg three times daily. Both routes nevertheless retain safety considerations. NSAID adverse effects include gastrointestinal ulceration, bleeding and perforation; kidney injury; and cardiovascular thrombotic events, including myocardial infarction and stroke. Risk assessment incorporates age, existing disease and concurrent medication. NICE specifies gastroprotective treatment, such as a proton pump inhibitor, alongside oral NSAID use; this addresses gastrointestinal risk rather than the full range of renal and cardiovascular toxicity. (dailymed.nlm.nih.gov)

Paracetamol, called acetaminophen in the United States, and opioids have more restricted roles in NICE’s treatment framework. NG226 states that paracetamol has no strong evidence of benefit in osteoarthritis and does not support routine use of either paracetamol or weak opioids. It limits their role to infrequent, short-term pain relief when other pharmacological treatments are contraindicated, poorly tolerated or ineffective. Strong opioids are not recommended because their risks outweigh their benefits; dependence and withdrawal are additional concerns addressed by associated NICE guidance. These recommendations concern symptom management: analgesic benefit is not evidence of cartilage regeneration or reversal of structural joint damage. (nice.org.uk)

Intra-articular corticosteroid injections deliver anti-inflammatory treatment directly into an affected joint. NICE considers them when other pharmacological treatments are ineffective or unsuitable, or when temporary symptom relief could support exercise, and describes their expected benefit as lasting approximately 2–10 weeks. Its evidence review found no demonstrated long-term benefit beyond three months. Repeated administration has also been examined separately from occasional injection. In a 2017 randomized controlled trial, Timothy E. McAlindon and colleagues assigned 140 participants with symptomatic knee osteoarthritis to triamcinolone 40 mg or saline injections every 12 weeks for two years. Mean cartilage-thickness loss was greater with triamcinolone, −0.21 mm versus −0.10 mm, without a significant difference in pain. These findings concern that repeated-injection regimen and do not directly measure the short-term response to a single injection. (nice.org.uk)

Other injected products and supplements have different evidential status. NICE advises against intra-articular hyaluronan injections, reporting that its reviewed evidence did not demonstrate improvements in pain, physical function or quality of life for knee or hip osteoarthritis. It also advises against glucosamine because strong evidence of benefit is lacking. Cell-based injections remain investigational within this guidance: NICE describes stem-cell treatment as experimental and confines its use to research. A 2022 NIAMS research roundtable likewise identified unresolved questions about platelet-rich plasma and mesenchymal stromal-cell preparations, including variable product composition, inconsistent clinical outcomes and uncertain structural effects. Their use or commercial availability therefore remains distinct from established evidence of joint-tissue restoration. (nice.org.uk)

Surgery and Postoperative Care

Surgical assessment is prompted by substantial joint-related pain, stiffness, deformity, or loss of function despite appropriate nonsurgical treatment. Relevant limitations include difficulty walking, climbing stairs, sleeping, or performing everyday activities. NICE’s 2022 guidance bases referral for joint replacement on clinical assessment and the effects on quality of life, rather than a numerical symptom score alone. Age, sex, smoking, comorbidities, and body mass index are not, by themselves, grounds for excluding referral, although individual circumstances influence operative risk and suitability. Assessment therefore distinguishes the indication for surgery from the evaluation of whether a particular procedure can be performed safely. (nice.org.uk)

Hip and knee replacement remove damaged joint surfaces and substitute artificial articulating components. In total hip replacement, the femoral head and the acetabular socket surface are replaced. Total knee replacement resurfaces the ends of the femur and tibia with metal components separated by a polyethylene bearing; the undersurface of the patella may also be resurfaced. Selected knees with damage confined to one compartment can undergo partial, or unicompartmental, replacement. These operations seek to reduce pain and restore useful movement at the operated joint. They do not treat osteoarthritis in other joints or reverse the biological susceptibility underlying the disease. (niams.nih.gov)

Joint-preserving or motion-eliminating operations have narrower applications. An osteotomy cuts and realigns bone to redistribute mechanical loading. For example, a tibial or femoral osteotomy can shift weight away from a damaged knee compartment when disease is predominantly one-sided and limb alignment contributes to uneven loading. Arthrodesis, or joint fusion, instead joins the bones across a painful joint, eliminating movement at that articulation. In selected foot or ankle disease, damaged cartilage is removed and screws or plates hold the bones together until union occurs. The trade-off is pain relief and stability at the cost of joint motion; failure of bone union and increased loading of adjacent joints are recognized complications. (orthoinfo.org)

Arthroscopic lavage washes material from the joint, while debridement removes or smooths damaged tissue; neither replaces the diseased articulation. Their limitations were demonstrated in J. Bruce Moseley and colleagues’ 2002 randomized controlled trial: 180 patients with knee osteoarthritis received lavage, debridement, or placebo surgery, with neither active procedure producing superior pain or functional outcomes over two years. NICE’s 2022 guidance consequently rejects lavage and debridement as treatments for osteoarthritis. This restriction is distinct from assessment of a separate mechanical lesion, such as a sizable loose fragment causing persistent objective locking. The Dutch Orthopaedic Association’s guideline identifies such locking as a circumstance in which arthroscopy may be considered; ordinary osteoarthritic pain is not the same indication. (nejm.org)

Postoperative rehabilitation addresses muscle weakness, restricted movement, walking, and independence in daily activities. NICE’s 2020 joint-replacement guideline specifies physiotherapy or occupational-therapy rehabilitation on the day of surgery where possible, and within 24 hours, with delay when clinically necessary. It includes mobilization, home exercises, and training for everyday tasks. Recovery assessment considers progress toward functional goals, including safe transfers, walking and stair use, alongside pain and movement. Before discharge, rehabilitation goals and access to support are established; supervised outpatient treatment is used when functional impairment persists or self-directed rehabilitation does not meet those goals. (nice.org.uk)

Recognized replacement-related complications include infection, loosening of components from bone, wear-associated bone loss, fracture around the implant, and, after hip replacement, dislocation. Some complications require revision surgery, in which components are exchanged or reconstructed. Recovery is not complete merely because the wound has healed or hospital discharge has occurred: NIAMS describes much hip-replacement recovery as occurring during the first two months, while strength and activity can continue improving over the following year. The pace and completeness of recovery vary with preoperative fitness, general health, and complications. (niams.nih.gov)

Research Development and Unresolved Questions

The shift from a predominantly “wear-and-tear” explanation to a whole-joint model changed both experimental targets and the design of osteoarthritis studies. The OARSI–FDA disease-state working group, whose report was published in 2011 by Nancy E. Lane and colleagues, described abnormalities involving cartilage, subchondral bone, menisci, synovium, and other joint tissues rather than cartilage attrition alone. It distinguished structural “disease” from the patient’s experience of “illness”—pain, stiffness, and functional limitations—and proposed evaluating these separately in clinical trials. This distinction also exposed unresolved questions about disease onset: an anatomical abnormality may predispose a joint to damage, whereas a similar-looking change may result from established disease. The report identified better characterization of disease phenotypes as necessary for more specific treatment selection. (oarsijournal.com)

The Osteoarthritis Initiative (OAI) provided a major longitudinal resource for investigating these questions. This multicenter, prospective observational cohort enrolled 4,796 adults aged 45–79 between February 2004 and May 2006, including people with symptomatic knee osteoarthritis and people at increased risk of developing it. Its research resources combine clinical assessments, radiographs, magnetic resonance imaging (MRI), and stored biological specimens. Four dedicated 3-tesla scanners, one at each clinical center, supported annual knee imaging during the initial four-year imaging program. Researchers can access the data and images, while access to specimens requires an application. Repeated observations allow investigators to examine whether an imaging or biochemical abnormality precedes disease onset or progression, rather than merely accompanying established damage. The cohort’s explicit purpose included evaluating candidate biomarkers as potential surrogate endpoints. (nia.nih.gov)

Research in genetics addresses inherited susceptibility and differences between affected joint sites. A 2021 genome-wide association meta-analysis examined 826,690 individuals from nine populations, connecting osteoarthritis-associated variants with joint-specific disease patterns and pain-related phenotypes to identify potential therapeutic targets. (pmc.ncbi.nlm.nih.gov) Studies of pain examine mechanisms that structural imaging alone cannot capture. In the Multicenter Osteoarthritis Study, an analysis of 1,111 participants combined MRI findings with pressure-pain thresholds and tests of temporal summation, in which repeated stimulation produces increasing pain. Synovitis was associated with lower pressure-pain thresholds at the knee and further sensitization over 24 months; joint effusion was associated with incident temporal summation. These observational findings support investigation of links between joint inflammation and altered pain processing, without establishing that the same mechanism explains pain in every affected person. (pmc.ncbi.nlm.nih.gov)

Imaging and biochemical research seek measures sensitive enough to detect early change and identify people likely to progress. Proposed measures include MRI cartilage thickness and volume, bone-marrow lesions, meniscal damage, synovitis, and serum or urinary markers of tissue turnover. (pmc.ncbi.nlm.nih.gov) External validation remains essential. In the FNIH Biomarkers Consortium’s PROGRESS OA analysis, 827 participants from the control arms of three completed trials were assessed for biochemical predictors of progression. Among 681 participants with both serum and urine samples, adding serum hyaluronan and urinary C2C-HUSA, a type II collagen cleavage marker, to body mass index and radiographic grade produced an area under the receiver-operating-characteristic curve of 0.627 for predicting joint-space loss of at least 0.7 mm, compared with 0.612 for the clinical and radiographic variables alone. Predictive performance therefore remained modest. (pmc.ncbi.nlm.nih.gov)

A central challenge for disease-modifying treatments is establishing whether structural improvement produces meaningful clinical benefit. In the 549-participant FORWARD randomized controlled trial, reported by Marc C. Hochberg and colleagues in 2019, sprifermin—a recombinant fibroblast growth factor 18—produced a 0.05-mm greater change in femorotibial cartilage thickness than placebo after two years in the 100-microgram, six-monthly treatment group. However, total Western Ontario and McMaster Universities Osteoarthritis Index scores did not differ significantly from placebo, and the clinical importance of the cartilage change was uncertain. (jamanetwork.com) Consequently, a marker that predicts progression cannot automatically substitute for outcomes such as pain or function; proposed surrogate endpoints require validation before they can establish treatment benefit. (fnih.org)

References

1. What is osteoarthritis?oarsi.org
2. Osteoarthritis - MeSH - NCBIncbi.nlm.nih.gov
3. Osteoarthritis Symptoms, Causes & Risk Factorsniams.nih.gov
4. Osteoarthritis (OA) - Rheumatology and Orthopedics - Merck Manual Professional Editionmerckmanuals.com
5. "Generalized osteoarthritis": a systematic reviewpubmed.ncbi.nlm.nih.gov
6. Osteoarthritiswho.int
7. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019rcastoragev2.blob.core.windows.net
8. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021rcastoragev2.blob.core.windows.net
9. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic reviewpubmed.ncbi.nlm.nih.gov
10. Osteoarthritis pathophysiology – therapeutic target discovery may require a multi-faceted approachpmc.ncbi.nlm.nih.gov
11. Meniscus and Cartilage Exhibit Distinct Intra-Tissue Strain Distributions Under Unconfined Compressionpmc.ncbi.nlm.nih.gov
12. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritisnature.com
13. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritisnature.com
14. Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritisnature.com
15. Homeostatic Mechanisms in Articular Cartilage and Role of Inflammation in Osteoarthritispmc.ncbi.nlm.nih.gov
16. The role of menisci in knee contact mechanics and secondary kinematics during human walkingpubmed.ncbi.nlm.nih.gov
17. Osteoarthritis Symptoms, Causes & Risk Factorsniams.nih.gov
18. Aging and oxidative stress reduce the response of human articular chondrocytes to insulin-like growth factor 1 and osteogenic protein 1pubmed.ncbi.nlm.nih.gov
19. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populationspubmed.ncbi.nlm.nih.gov
20. Living With Arthritis: Health Information Basics for You and Your Familyniams.nih.gov
21. Is leptin the missing link between osteoarthritis and obesity?pubmed.ncbi.nlm.nih.gov
22. The relationship between hand osteoarthritis and serum leptin concentration in participants of the Third National Health and Nutrition Examination Surveypubmed.ncbi.nlm.nih.gov
23. High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injurypubmed.ncbi.nlm.nih.gov
24. Is There an Association Between a History of Running and Symptomatic Knee Osteoarthritis? A Cross-Sectional Study From the Osteoarthritis Initiativepubmed.ncbi.nlm.nih.gov
25. Occupational physical activities and osteoarthritis of the kneepubmed.ncbi.nlm.nih.gov
26. Varus and valgus alignment and incident and progressive knee osteoarthritispubmed.ncbi.nlm.nih.gov
27. Acetabular dysplasia predicts incident osteoarthritis of the hip: the Rotterdam studypubmed.ncbi.nlm.nih.gov
28. Osteonecrosis (Avascular Necrosis) Symptoms & Causesniams.nih.gov
29. Arthritis of the Knee - OrthoInfo - AAOSorthoinfo.aaos.org
30. Hip Osteoarthritis - OrthoInfo - AAOSorthoinfo.aaos.org
31. Osteoarthritis of the Handassh.org
32. Facet Joints of the Spine: Structure-Function Relationships, Problems and Treatments, and the Potential for Regenerationpubmed.ncbi.nlm.nih.gov
33. Facet joint osteoarthritis and low back pain in the community-based populationpubmed.ncbi.nlm.nih.gov
34. Triggers for acute flare in adults with, or at risk of, knee osteoarthritis: a web-based case-crossover study in community-dwelling adults.pubmed.ncbi.nlm.nih.gov
35. Trajectories and Risk Profiles of Pain in Persons with Radiographic, Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiativepmc.ncbi.nlm.nih.gov
36. Osteoarthritis: Diagnosis, Treatment, and Steps to Takeniams.nih.gov
37. Recommendations | Osteoarthritis in over 16s: diagnosis and management | Guidance | NICEnice.org.uk
38. Rationale and impact | Osteoarthritis in over 16s: diagnosis and management | Guidance | NICEnice.org.uk
39. Radiological assessment of osteo-arthrosispubmed.ncbi.nlm.nih.gov
40. Assessing Radiographic Knee Osteoarthritis: An Online Training Tutorial for the Kellgren-Lawrence Grading Scalepmc.ncbi.nlm.nih.gov
41. Rheumatoid Arthritis: Diagnosis, Treatment, and Steps to Takeniams.nih.gov
42. Gout: Diagnosis, Treatment, and Steps to Takeniams.nih.gov
43. Guideline for management of septic arthritis in native joints (SANJO)jbji.copernicus.org
44. Osteoarthritis | Healthhealth.nih.gov
45. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trialpubmed.ncbi.nlm.nih.gov
46. The Intensive Diet and Exercise for Arthritis (IDEA) trial: 18-month radiographic and MRI outcomespmc.ncbi.nlm.nih.gov
47. Nonsteroidal Antiinflammatory Drugs (NSAIDs)ncbi.nlm.nih.gov
48. DailyMed: Diclofenac sodium geldailymed.nlm.nih.gov
49. DailyMed: Voltaren—diclofenac sodium geldailymed.nlm.nih.gov
50. DailyMed: Diclofenac sodium—diclofenac sodium topical geldailymed.nlm.nih.gov
51. Cartilage Preservation and Restoration in Knee Osteoarthritis: Challenges, Gaps, and Opportunities Roundtable—September 2022niams.nih.gov
52. Total Knee Replacement - OrthoInfo - AAOSorthoinfo.org
53. Hip Replacement: What to Expect & How to Prepare | NIAMSniams.nih.gov
54. Knee Replacement Implants - OrthoInfo - AAOSorthoinfo.org
55. Knee Replacementorthoinfo.aaos.org
56. Osteotomy of the Knee - OrthoInfo - AAOSorthoinfo.org
57. Arthritis of the Foot and Ankle - OrthoInfo - AAOSorthoinfo.org
58. Dutch Guideline on Knee Arthroscopy Part 2: non-meniscus intra-articular knee injury: a multidisciplinary review by the Dutch Orthopaedic Associationpmc.ncbi.nlm.nih.gov
59. Recommendations | Joint replacement (primary): hip, knee and shouldernice.org.uk
60. Rationale and impact | Joint replacement (primary): hip, knee and shouldernice.org.uk
61. Osteoarthritis Initiative (OAI)nia.nih.gov
62. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populationspmc.ncbi.nlm.nih.gov
63. Association of Joint Inflammation With Pain Sensitization in Knee Osteoarthritis: The Multicenter Osteoarthritis Studypmc.ncbi.nlm.nih.gov
64. Biomarkers in osteoarthritis: current status and outlook — the FNIH Biomarkers Consortium PROGRESS OA studypmc.ncbi.nlm.nih.gov
65. Biochemical biomarkers of knee osteoarthritis progression: Results from the FNIH biomarkers consortium progress OA studypmc.ncbi.nlm.nih.gov